Force Majeure Event Notification – COVID-19

Dear Partner,

Due to the circumstances related to COVID-19 declaration of emergency, Synergy Swiss Pharma Group will have to comply and support all contingency measures imposted by Swiss Health Authorities, due
to a global rupture in supply chain of medicines, API’s and other raw materials, that affect directly our capacity to export medicines and other health products. Also, the quarantine and preventive measures imposed in people’s circulation will have serious impact in our labor capacity.

The actual conditions and the imposed restrictions represent a Force Majeure event that will conditionate Synergy Group to timely comply with the orders received from its clients.

Probably it will also create delays in audits, sending of official documentation, and similar activities.

Synergy Group started and will maintain the best efforts in order to reinforce its production capacity and also activated its risk management plan for materials shortage. We are now working to obtain solutions that may allow us to satisfy all confirmed pending orders from our clients.


We ask our clients and partners to consider this Force Majeure event notification and please revise your plans accordingly.

Your contact person in Synergy Group will remain available in order to manage and update situation.


We may assure our best efforts to overcome this emergency situation and count with your understanding.

With best regards.
Fabrice Vanin
Managing Director

Swiss Synergy Pharma is well-positioned to bring

cutting-edge solutions

TO THE MARKET

We are open for new partnerships

SYNERGY SWISS PHARMA

BUSINESS DEVELOPMENT

SYNERGY SWISS PHARMA

ENGINEERING

SYNERGY SWISS PHARMA

NICOTINE

Synergy Swiss Pharma Sagl

Via Luigi Lavizzari 4, 6850 Mendrisio - Switzerland
+41 (0) 91 980 91 62
+41 (0) 91 930 70 71
barbara@synergypharma.ch

NEW OPENING

MALAYSIA

WITH DISTRIBUTION IN WHOLE ASIA FOR API AND FDF